| Wesley Prichard, DO | |
|
13952 Denver West Pkwy Ste 100, Lakewood, CO 80401-3141 | |
| (303) 604-5000 | |
| Not Available |
| Full Name | Wesley Prichard |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 10 Years |
| Location | 13952 Denver West Pkwy Ste 100, Lakewood, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194142166 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lutheran Medical Center | Wheat ridge, CO | Hospital |
| Saint Joseph Hospital | Denver, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boulder Valley Gastroenterology Inc. | 4688577174 | 48 |
News Archive
Researchers in Hong Kong have found that patients newly diagnosed with coronary artery disease had almost twice the prevalence of colorectal tumors and cancers; they say this was more so among those who had smoked or had metabolic syndrome.
A new study of patterns of brain communication in toddlers with autism shows evidence of aberrant neural communication even at this relatively early stage of brain development. The results are presented in an article in Brain Connectivity, a bimonthly peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
11th World Stroke Congress brings together leading international stroke experts and an unparalleled scientific program covering epidemiology, prevention, acute care, recovery and rehabilitation in 100s of sessions and oral posters.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data from two pivotal Phase III efficacy trials for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. In the studies, suvorexant significantly reduced the time it took patients to fall asleep and increased the time that patients stayed asleep as early as the first night and at the three-month time point compared to placebo. The investigational medicine met statistical significance for all primary endpoints except for one measurement at Month 3 in one of the trials. These late-breaking data were presented here today at SLEEP 2012, the 26th Annual Meeting of the Associated Professional Sleep Societies.
› Verified 7 days ago
| Entity Name | Boulder Valley Gastroenterology Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902832603 PECOS PAC ID: 4688577174 Enrollment ID: O20040130001035 |
News Archive
Researchers in Hong Kong have found that patients newly diagnosed with coronary artery disease had almost twice the prevalence of colorectal tumors and cancers; they say this was more so among those who had smoked or had metabolic syndrome.
A new study of patterns of brain communication in toddlers with autism shows evidence of aberrant neural communication even at this relatively early stage of brain development. The results are presented in an article in Brain Connectivity, a bimonthly peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
11th World Stroke Congress brings together leading international stroke experts and an unparalleled scientific program covering epidemiology, prevention, acute care, recovery and rehabilitation in 100s of sessions and oral posters.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data from two pivotal Phase III efficacy trials for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. In the studies, suvorexant significantly reduced the time it took patients to fall asleep and increased the time that patients stayed asleep as early as the first night and at the three-month time point compared to placebo. The investigational medicine met statistical significance for all primary endpoints except for one measurement at Month 3 in one of the trials. These late-breaking data were presented here today at SLEEP 2012, the 26th Annual Meeting of the Associated Professional Sleep Societies.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wesley Prichard, DO 382 S Arthur Ave, Louisville, CO 80027-3094 Ph: (303) 604-5000 | Wesley Prichard, DO 13952 Denver West Pkwy Ste 100, Lakewood, CO 80401-3141 Ph: (303) 604-5000 |
News Archive
Researchers in Hong Kong have found that patients newly diagnosed with coronary artery disease had almost twice the prevalence of colorectal tumors and cancers; they say this was more so among those who had smoked or had metabolic syndrome.
A new study of patterns of brain communication in toddlers with autism shows evidence of aberrant neural communication even at this relatively early stage of brain development. The results are presented in an article in Brain Connectivity, a bimonthly peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
11th World Stroke Congress brings together leading international stroke experts and an unparalleled scientific program covering epidemiology, prevention, acute care, recovery and rehabilitation in 100s of sessions and oral posters.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data from two pivotal Phase III efficacy trials for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. In the studies, suvorexant significantly reduced the time it took patients to fall asleep and increased the time that patients stayed asleep as early as the first night and at the three-month time point compared to placebo. The investigational medicine met statistical significance for all primary endpoints except for one measurement at Month 3 in one of the trials. These late-breaking data were presented here today at SLEEP 2012, the 26th Annual Meeting of the Associated Professional Sleep Societies.
› Verified 7 days ago
Dr. Matthew Seto, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 13952 Denver West Pkwy Ste 100, Lakewood, CO 80401 Phone: 303-604-5000 Fax: 720-890-0364 | |
Dr. Kimberly Inez Rieniets, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 215 S Wadsworth Blvd Ste 530, Lakewood, CO 80226 Phone: 720-447-8837 Fax: 888-531-4959 | |
Debra Dyer, LPN Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 8383 W Alameda Ave, Lakewood, CO 80226 Phone: 303-239-7320 | |
Stephen J Frank, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 34 Van Gordan St, Ste 160, Lakewood, CO 80228 Phone: 303-430-2700 Fax: 303-430-2770 | |
Dr. Paula F Dennen, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 274 Union Blvd, Suite 110, Lakewood, CO 80228 Phone: 303-951-0600 Fax: 303-951-0605 | |
Chia-yen Lien, Gastroenterology Medicare: Medicare Enrolled Practice Location: 8383 W Alameda Ave, Lakewood, CO 80226 Phone: 303-338-4545 | |
Dr. Andrew Steffes Korson, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 7000 W Colfax Ave, Lakewood, CO 80214 Phone: 303-573-9951 |